Autolus Therapeutics (AUTL) Cash & Current Investments (2017 - 2026)
Autolus Therapeutics (AUTL) reported Cash & Current Investments of $201.63 million for Q2 2026, down 55.6% from $454.33 million a year earlier.
Powered by 
Analysis
Autolus Therapeutics (AUTL) Cash & Current Investments (2017 - 2026) Analysis & Trends
At the end of FY2025, Autolus Therapeutics posted Cash & Current Investments of $300.71 million, down 48.9% from FY2024.
- Cash & Current Investments has a four-year compound annual growth rate of -0.8% (FY2021 to FY2025).
- By year, Cash & Current Investments came in at $588.02 million in FY2024 (+145.5%), $239.57 million in FY2023 (-37.4%), $382.44 million in FY2022 (+23.2%) and $310.34 million in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Cash & Current Investments since Q3 2022.
- Year over year, Cash & Current Investments gained in two of the last seven quarters, with growth averaging 12.2%.
- The high point for year-over-year Cash & Current Investments in five years was Q3 2024 (growth of 156.3%); the low point was Q2 2026 (a decline of 55.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Autolus Therapeutics | 631.98 Mn | -692.11 Mn | 25.22 Mn | 201.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 201.63 Mn |
| Dec 31, 2025 | 300.71 Mn |
| Sep 30, 2025 | 367.42 Mn |
| Jun 30, 2025 | 454.33 Mn |
| Mar 31, 2025 | 516.60 Mn |
| Dec 31, 2024 | 588.02 Mn |
| Sep 30, 2024 | 657.07 Mn |
| Jun 30, 2024 | 705.94 Mn |
| Mar 31, 2024 | 758.53 Mn |
| Dec 31, 2023 | 239.57 Mn |
| Sep 30, 2023 | 256.42 Mn |
| Jun 30, 2023 | 307.50 Mn |
| Mar 31, 2023 | 343.03 Mn |
| Dec 31, 2022 | 382.44 Mn |
| Sep 30, 2022 | 163.05 Mn |
| Jun 30, 2022 | 216.44 Mn |
| Mar 31, 2022 | 268.56 Mn |
| Dec 31, 2021 | 310.34 Mn |
| Sep 30, 2021 | 173.06 Mn |
| Jun 30, 2021 | 216.35 Mn |
API Access
Autolus Therapeutics Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AUTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "AUTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=AUTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();